Freed E O, Myers D J, Risser R
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4. doi: 10.1073/pnas.87.12.4650.
The human immunodeficiency virus transmembrane glycoprotein gp41 has at its amino terminus a strongly hydrophobic stretch of 28 amino acids flanked by a highly conserved series of polar amino acids. To investigate the role in syncytium formation of the hydrophobic amino terminus of gp41 and the polar border of this hydrophobic region, we introduced eight single-amino acid substitutions and one double-amino acid substitution in the amino-terminal 31 amino acids of gp41. The mutant envelope glycoproteins were expressed from two distinct human immunodeficiency virus type 1 envelope glycoprotein expression vectors; the effects of the mutations on syncytium formation, envelope glycoprotein transport, secretion, and CD4 receptor-binding were analyzed. Results showed that polar substitutions throughout the hydrophobic amino terminus of gp41 greatly reduced or blocked syncytium formation mediated by the human immunodeficiency virus type 1 envelope glycoproteins, as did nonconservative mutations in the polar border of the hydrophobic amino terminus. Mutations at gp41 amino acids 15, 26, and 29 also significantly increased the extent of gp120 secretion into the extracellular medium. None of the mutations detectably affected envelope glycoprotein processing or envelope glycoprotein binding to CD4.
人类免疫缺陷病毒跨膜糖蛋白gp41在其氨基末端有一段由28个氨基酸组成的高度疏水序列,两侧是一系列高度保守的极性氨基酸。为了研究gp41疏水氨基末端以及该疏水区域的极性边界在合胞体形成中的作用,我们在gp41的氨基末端31个氨基酸中引入了8个单氨基酸替换和1个双氨基酸替换。突变的包膜糖蛋白由两种不同的1型人类免疫缺陷病毒包膜糖蛋白表达载体表达;分析了这些突变对合胞体形成、包膜糖蛋白运输、分泌以及CD4受体结合的影响。结果表明,gp41疏水氨基末端的极性替换极大地减少或阻断了1型人类免疫缺陷病毒包膜糖蛋白介导的合胞体形成,疏水氨基末端极性边界的非保守突变也有同样的效果。gp41第15、26和29位氨基酸的突变也显著增加了gp120分泌到细胞外培养基中的程度。所有突变均未检测到对包膜糖蛋白加工或包膜糖蛋白与CD4结合有影响。